Petnet Solutions, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1350 MANUFACTURING ST STE 105, DALLAS, Texas (TX) 75207, United States (USA)
- Operations here
- positron emission tomography drug production
- FDA identifiers
- FEI 3007844012 · DUNS 799246256
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-12-11
- VAIDrug Quality Assurance2017-05-22
Drugs this plant is listed as making
3 distinct drugs across 3 products name this site in their FDA label.
- Fluciclovine F-18Blue Earth Diagnostics
- Fluoroestradiol F 18GE Healthcare Inc.
- Piflufolastat F-18Progenics Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.